Summary

LFB (Laboratoire Français du Fractionnement et des Biotechnologies) is a leading French biopharmaceutical group specializing in the development, manufacturing, and marketing of plasma-derived medicinal products and recombinant proteins. Founded in 1994, the company has established itself as a pillar of French healthcare sovereignty and an internationally recognized force in the plasma industry. LFB focuses on treating serious and often rare diseases across three major therapeutic areas: immunology, haemostasis, and intensive care. As the leading manufacturer of plasma-derived medicinal products in France and the fifth largest worldwide, LFB markets approximately fifteen biomedicinal products in over 30 countries. The company operates five bioproduction sites globally and employs around 3,000 professionals dedicated to fulfilling its public health mission. LFB's commitment to research and development, combined with its innovative rPRO Technology™ platform for recombinant protein production, positions it as a key player in advancing treatments for unmet medical needs in rare disease therapeutics.

Job description

Specific Position Duties (Responsibilities, Tasks, Essential Functions)

Daily animal care activities to include: feeding, animal observations/identification of clinical concerns, and nail trimming
Husbandry activities to include cage change/cleaning, use of power wash and chemical dispensing equipment, and general facility sanitization and support
Milking of rabbits and standard support activities to meet production goals and adherence to established schedules
Proper restraint of rabbits to facilitate general animal care, transfers, sample collection, and advanced handling (AI restraint)
Technical skills to include IM, IV, SC, and IP injections, and IV blood collection procedures
Assess animals, initiate veterinary care and execute animal treatments
Perform animal identification applications to include ear tags, tattoos and RFID transponders
May perform and provide support, to include updating of records, for natural and artificial insemination breeding procedures, pregnancy palpation and kindling/weaning procedures
Utilize computer and paper-based systems to accurately document and/or record information to assure compliance with applicable regulations, and company policies
Have an understanding of applicable Quality Systems (e.g. change control, deviations)
May write, modify, and provide training (as assigned) on SOPs/WI/TM
Demonstrate the ability to work on assigned projects independently with little or no supervision
Identify safety issues and initiate corrective actions to reach resolution
Identify and communicate animal welfare concerns
Exhibit a sound understanding of applicable animal care and use guidelines
Weekend and holiday coverage required on a rotating basis

Requirements

Proficiency in animal handling and restraint
Technical clinical skills including injections and blood collection
Ability to work independently with minimal supervision
Understanding of animal welfare guidelines
Availability for rotating weekend and holiday coverage

Company overview

LFB (Laboratoire Français du Fractionnement et des Biotechnologies) is a leading French biopharmaceutical group specializing in the development, manufacturing, and marketing of plasma-derived medicinal products and recombinant proteins. Founded in 1994, the company has established itself as a pillar of French healthcare sovereignty and an internationally recognized force in the plasma industry. LFB focuses on treating serious and often rare diseases across three major therapeutic areas: immunology, haemostasis, and intensive care. As the leading manufacturer of plasma-derived medicinal products in France and the fifth largest worldwide, LFB markets approximately fifteen biomedicinal products in over 30 countries. The company operates five bioproduction sites globally and employs around 3,000 professionals dedicated to fulfilling its public health mission. LFB's commitment to research and development, combined with its innovative rPRO Technology™ platform for recombinant protein production, positions it as a key player in advancing treatments for unmet medical needs in rare disease therapeutics.